PetMed Express Rides High with Strong Sales in Pet Pharmacy Market PetMed Express, Inc., a leading pet pharmacy operating in the United States, announced strong sales figures for the latest quarter. The company's total sales rose 7.3% year-over-year to $79.8 million, and net income was up by 23.7% to $8.8 million. PetMed Express markets prescription and non-prescription pet medications, health products, and other supplies primarily for dogs, cats, and horses. Its products range from flea and tick control to vitamins and nutritional supplements. The company takes pride in providing both prescription and non-prescription products, offering specialty medication for dogs and cats with arthritis, thyroid issues, diabetes, and more. Its generic program allows pet owners to save money while still providing quality medication for their furry friends. PetMed Express sells its products through several channels, including its website, mobile app, telephone contact center, and direct mail/print. Its branding has also extended to television advertising with its well-recognized 1-800-PetMeds and PetMeds brands. The Florida-based company, incorporated in 1996, has seen a bump in sales from the pandemic pet boom. Pet ownership increased last year, and as more people work remotely, pet parents have increased their spend on companion animals. The market trend is favourable to pet pharmacy companies like PetMed Express, which are experiencing steady growth as more pet owners seek convenient and affordable ways to provide their pets with health products and medication.
Pets at Home Group's ticker is PETS
The company's shares trade on the NASDAQ stock exchange
They are based in Pompano Beach, Florida
There are 51-200 employees working at Pets at Home Group
It is investors.petsathome.com
Pets at Home Group is in the Healthcare sector
Pets at Home Group is in the Drug Delivery industry
The following five companies are Pets at Home Group's industry peers: